Fondazione Telethon
ERDERA Clinical Trial Call
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
The ERDERA Clinical Trial Call, run in Italy by Fondazione Telethon as part of the European Rare Diseases Research Alliance (ERDERA), funds clinical trials on rare diseases that require a transnational consortium and access to patient-sample or clinical infrastructure. It targets researchers working at TRL 4-7, meaning the project must already have moved past basic discovery toward clinical testing. The call runs annually and is open to Italian applicants participating in an ERDERA transnational consortium.
Details
| Funder | Fondazione Telethon |
| Deadline | 16 November 2026 |
| Consortium | Required — transnational consortium under the European Rare Diseases Research Alliance (ERDERA) |
| TRL | 4-7 |
| Frequency | Annual |
| Eligible countries | IT |
Eligibility & scope
Call for clinical trials on rare diseases under the ERDERA (European Rare Diseases Research Alliance) joint transnational initiative, with clinical-trial scope requiring patient-sample/clinical infrastructure.
Who Should Apply
- •Researchers in Italy with access to clinical-trial and patient-sample infrastructure
- •Teams working on rare disease therapeutics at TRL 4-7
- •Applicants able to join a transnational consortium under the ERDERA joint initiative
- •Clinical and translational researchers rather than purely basic-science teams
Key Dates
- •Deadline: 16 November 2026
- •Call frequency: annual
- •Consortium required: transnational, under the ERDERA joint initiative
Tips for Applicants
- ✓Confirm your consortium's ERDERA eligibility and partner roles well before the deadline, since transnational coordination takes time to assemble.
- ✓Document existing clinical infrastructure and patient-sample access explicitly, the TRL 4-7 scope means reviewers expect clinical readiness, not preclinical plans.
- ✓Check Fondazione Telethon's national call text for Italy-specific administrative and funding-eligibility rules alongside the ERDERA joint call rules.
Frequently Asked Questions
What does the ERDERA Clinical Trial Call fund?
It funds clinical trials on rare diseases that fall within TRL 4-7 and require patient-sample or clinical infrastructure, run under the ERDERA transnational initiative.
Who can apply to the ERDERA Clinical Trial Call through Fondazione Telethon?
Eligible applicants are based in Italy and must participate in a transnational consortium under the European Rare Diseases Research Alliance.
Is a consortium required for this call?
Yes, applicants must form part of a transnational consortium under the ERDERA joint initiative.
How often does the ERDERA Clinical Trial Call run?
It is an annual call.
When is the deadline for the ERDERA Clinical Trial Call?
The deadline is 16 November 2026.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
ERDERA Clinical Trial Call
Fondazione TelethonDeadline: 16 Nov 2026Project grant for international collaboration within health research (ERA4HEALTH)
Swedish Research CouncilDeadline: 21 Jan 2027Cell and Gene Therapy for Personalised Medicine
Research Council of NorwayDeadline: 20 Jan 2027Fall Seed Grant 2026
Fondazione TelethonHealth Research Call
la Caixa FoundationDeadline: 18 Nov 2026Up to €500,000 for individual projects; up to €1,000,000 for research consortium projects
Browse Related
Could ERDERA Clinical Trial Call be right for you?
Closes in 9 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →